Phase 2 Pulmonary Hypertension Trial, Recruiting (NCT07063888)

Phase 2 Pulmonary Hypertension Trial, Recruiting NCT07063888 Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Condition: Pulmonary Hypertension

Printed from Voxsanity (voxsanity.com.au) — NCT07063888 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pulmonary Hypertension

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 18 and 80 years old
You have had surgery as the main treatment for your condition
After surgery, lab tests confirmed you have a type of bile duct cancer that started inside the liver (called intrahepatic cholangiocarcinoma)
Your surgical results showed either that the cancer was removed with a very small margin of healthy tissue (less than 1cm) around it, or that cancer was found in nearby lymph nodes
Your surgeon was able to remove the tumor completely or nearly completely (no visible cancer left behind)
Your liver is functioning well enough after surgery, based on a standard liver health score (confirm with trial site)
If a large proportion of your removed lymph nodes contained cancer, or if cancer spread to certain specific lymph node areas, you must have had a special full-body scan (PET-CT) before surgery or radiation to confirm the cancer has not spread to distant parts of the body
You have had a detailed liver scan (contrast-enhanced MRI) after surgery to confirm there are no additional small cancer spots in the liver
You have recovered from surgery and are able to carry out basic daily activities, based on a standard health scale rated 0 to 2 (confirm with trial site)
Doctors estimate you are expected to live for more than 3 months

Who may not be able to join:

You have had another type of cancer in the past, unless it was a specific type of minor skin cancer or very early-stage cervical cancer
You have previously had radiation treatment to your abdomen (belly area)
You have previously had a liver transplant
You have a serious heart condition or severe kidney failure
You had a noticeable build-up of fluid in your abdomen (causing symptoms) within 4 months after surgery
It has been 4 months or more since your surgery

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 00861324000876

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07063888

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase: Phase 2

Status: Recruiting

Condition: Pulmonary Hypertension

Trial contact: 00861324000876

More information: https://clinicaltrials.gov/study/NCT07063888

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 18 and 80 years old
You have had surgery as the main treatment for your condition
After surgery, lab tests confirmed you have a type of bile duct cancer that started inside the liver (called intrahepatic cholangiocarcinoma)
Your surgical results showed either that the cancer was removed with a very small margin of healthy tissue (less than 1cm) around it, or that cancer was found in nearby lymph nodes
Your surgeon was able to remove the tumor completely or nearly completely (no visible cancer left behind)
Your liver is functioning well enough after surgery, based on a standard liver health score (confirm with trial site)
If a large proportion of your removed lymph nodes contained cancer, or if cancer spread to certain specific lymph node areas, you must have had a special full-body scan (PET-CT) before surgery or radiation to confirm the cancer has not spread to distant parts of the body
You have had a detailed liver scan (contrast-enhanced MRI) after surgery to confirm there are no additional small cancer spots in the liver
You have recovered from surgery and are able to carry out basic daily activities, based on a standard health scale rated 0 to 2 (confirm with trial site)
Doctors estimate you are expected to live for more than 3 months

Who may not be able to join:

You have had another type of cancer in the past, unless it was a specific type of minor skin cancer or very early-stage cervical cancer
You have previously had radiation treatment to your abdomen (belly area)
You have previously had a liver transplant
You have a serious heart condition or severe kidney failure
You had a noticeable build-up of fluid in your abdomen (causing symptoms) within 4 months after surgery
It has been 4 months or more since your surgery

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 2

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Registry

ClinicalTrials.gov

Start date

16 May 2025

Est. completion

15 May 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Two-year Disease-free Survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov